NCT02686177View on ClinicalTrials.gov

Effect of GLP-1 on Angiogenesis

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 18, 2016

Primary Completion Date

August 8, 2017

Study Completion Date

May 28, 2021

Conditions
Type 2 Diabetes
Interventions
DRUG

Liraglutide

DRUG

Metformin or sulfonylurea

Trial Locations (1)

13005

Nutrition department, pole ENDO - Assistance Publique Hôpitaux Marseille, Marseille

All Listed Sponsors
lead

Assistance Publique - Hôpitaux de Paris

OTHER

NCT02686177 - Effect of GLP-1 on Angiogenesis | Biotech Hunter | Biotech Hunter